Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA
• The FDA asked for more data to determine whether Disc Medicine’s bitopertin is benefiting patients with erythropoietic protoporphyria, a rare blood disorder. • Analysts say it’s